RNA5SP480

Across TCGA pan-cancer cohorts, RNA5SP480 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP480 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNA5SP480 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP480 expression acts as an unfavorable survival marker.

THCA, CESC, and PAAD are the cancer types where RNA5SP480 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.049	0.828	<.001	54	view →
CESC	DFS	Tertile	All	0.193	0.740	.010	36	view →
PAAD	OS	Tertile	All	0.117	0.640	.007	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNA5SP480–THCA (DFS)

Open the THCA breakdown →